ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2020
Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity.
Muluken Altaye Ayza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papertrialcites it